Skip to Main Content
Christmas Tree
NEW YEAR SALE

50% off your first year of Quiver Premium

...

Use Promo Code:

NYE26BANNER
Christmas Tree Snow
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: Director at $MNPR Sells 461 Shares

Automated

ARTHUR J KLAUSNER, a director at $MNPR, sold 461 shares of the company on 12-18-2025 for an estimated $31,389. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.0% of their shares of this class of stock. Following this trade, they now own 8,762 shares of this class of $MNPR stock.

$MNPR Insider Trading Activity

MNPR Insider Trades

$MNPR insiders have traded $MNPR stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $MNPR stock by insiders over the last 6 months:

  • PHARMA LLC TACTIC sold 550,229 shares for an estimated $34,999,956
  • CHRISTOPHER M STARR sold 16,800 shares for an estimated $672,020
  • CHANDLER ROBINSON (Chief Executive Officer) sold 16,800 shares for an estimated $672,020
  • KIM R TSUCHIMOTO sold 8,904 shares for an estimated $356,170
  • ARTHUR J KLAUSNER has made 0 purchases and 2 sales selling 5,121 shares for an estimated $343,889.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$MNPR Hedge Fund Activity

We have seen 32 institutional investors add shares of $MNPR stock to their portfolio, and 27 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$MNPR Analyst Ratings

Wall Street analysts have issued reports on $MNPR in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Chardan Capital issued a "Buy" rating on 11/13/2025
  • Leerink Partners issued a "Outperform" rating on 11/10/2025
  • Barclays issued a "Overweight" rating on 10/13/2025
  • Oppenheimer issued a "Outperform" rating on 10/02/2025
  • HC Wainwright & Co. issued a "Buy" rating on 09/29/2025
  • Piper Sandler issued a "Overweight" rating on 09/25/2025
  • BTIG issued a "Buy" rating on 09/25/2025

To track analyst ratings and price targets for $MNPR, check out Quiver Quantitative's $MNPR forecast page.

$MNPR Price Targets

Multiple analysts have issued price targets for $MNPR recently. We have seen 10 analysts offer price targets for $MNPR in the last 6 months, with a median target of $105.5.

Here are some recent targets:

  • Chris Raymond from Raymond James set a target price of $123.0 on 11/14/2025
  • Keay Nakae from Chardan Capital set a target price of $100.0 on 11/13/2025
  • Joseph Schwartz from Leerink Partners set a target price of $115.0 on 11/10/2025
  • Etzer Darout from Barclays set a target price of $125.0 on 10/13/2025
  • Andreas Argyrides from Oppenheimer set a target price of $115.0 on 10/02/2025
  • Andres Y. Maldonado from HC Wainwright & Co. set a target price of $105.0 on 09/29/2025
  • Biren Amin from Piper Sandler set a target price of $95.0 on 09/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles